Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan.
Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Neurourol Urodyn. 2020 Jun;39(5):1345-1354. doi: 10.1002/nau.24385. Epub 2020 May 11.
We examined the time course of urodynamic changes and the effect of the short or long-term inhibition of brain-derived neurotrophic factor (BDNF) from the early phase after spinal cord injury (SCI) in mice.
The spinal cord of female C57BL/6N mice was completely transected. We examined filling cystometry and bladder BDNF levels at 10, 20, and 30 days after SCI, with an additional day-5 measurement of BDNF. In a separate group of mice, anti-BDNF antibody (Ab) (10 µg/kg/h) was subcutaneously administered using osmotic pumps from day 3 after SCI, and single-filling cystometry was performed at 10 and 30 days (7 and 27 days of treatment, respectively) after SCI.
Compared to spinal intact mice, bladder mucosal BDNF was increased at each time point after SCI with the maximal level at day 5 after SCI. Voiding efficiency was lower at each time point after SCI than that of spinal intact mice. The number of non-voiding contractions (NVC) during bladder filling was gradually increased with time. In both 10- and 30-day SCI groups treated with anti-BDNF Ab, voiding efficiency was improved, and the duration of notch-like intravesical pressure reductions during voiding bladder contractions was prolonged. The number of NVC was significantly decreased only in 30-day SCI mice with 27-day anti-BDNF treatment.
Overexpression of BDNF is associated with the deterioration of voiding efficiency after SCI. The early-started, long-term inhibition of BDNF improved voiding dysfunction and was also effective to reduce the later-phase development of detrusor overactivity after SCI.
我们研究了脑源性神经营养因子(BDNF)在脊髓损伤(SCI)后早期的短期或长期抑制对尿动力学变化的时间过程及作用。
雌性 C57BL/6N 小鼠的脊髓完全横断。我们检测了 SCI 后 10、20 和 30 天的充盈性膀胱测压和膀胱 BDNF 水平,并在第 5 天增加了 BDNF 的检测。在另一组小鼠中,从 SCI 后第 3 天开始,通过渗透泵皮下给予抗 BDNF 抗体(Ab)(10μg/kg/h),并在 SCI 后 10 和 30 天(分别为 7 和 27 天的治疗)进行单次充盈性膀胱测压。
与脊髓完整的小鼠相比,SCI 后每个时间点膀胱黏膜 BDNF 均增加,最大水平在 SCI 后第 5 天。SCI 后各时间点的排尿效率均低于脊髓完整的小鼠。在膀胱充盈过程中,无排尿收缩(NVC)的数量逐渐增加。在接受抗 BDNF Ab 治疗的 10 天和 30 天 SCI 组中,排尿效率得到改善,并且在排尿膀胱收缩期间,膀胱内压力降低的 notch 样持续时间延长。只有在接受 27 天抗 BDNF 治疗的 30 天 SCI 小鼠中,NVC 的数量才显著减少。
BDNF 的过度表达与 SCI 后排尿效率的恶化有关。早期开始的、长期的 BDNF 抑制改善了排尿功能障碍,并且对 SCI 后逼尿肌过度活动的后期发展也有效。